Navigation Links
Lockheed Martin Named Biometrics 'Company of the Year' by Frost and Sullivan
Date:3/4/2009

Award Recognizes Leadership in Technology and Innovation in Global Biometrics

GAITHERSBURG, Md., March 4 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) has been named the Biometrics Systems Integrator "Company of the Year" by Frost and Sullivan, recognizing the Corporation's leadership in developing innovative biometrics solutions for a wide range of customers. Frost and Sullivan based the award on a rigorous analysis of the worldwide biometrics marketplace, including factors such as customer satisfaction, industry leadership, growth and performance.

"Biometrics is an increasingly important component of our government customers' ability to apply 'smart power' in addressing today's global security challenges," said Linda Gooden, Executive Vice President of Lockheed Martin Information Systems and Global Services. "We're honored to have been selected for this prestigious award, and proud to support the law enforcement, homeland security and defense communities with leading-edge biometrics solutions."

As part of its rigorous selection process, Frost and Sullivan interviewed executives from across government and industry, measured growth and performance of biometrics market participants, and evaluated marketing and public relations efforts. Frost and Sullivan analysts then ranked each company according to pre-established criteria.

"Lockheed Martin has been able to maintain commendable growth in the biometrics market by virtue of well-planned, growth-oriented strategies," noted Frost and Sullivan Research Analyst Neelima Sagar. "This award recognizes Lockheed Martin's pioneering ability in developing a strong brand name and innovative technologies all while capturing a leading global market position. To enhance its service offerings and strengthen its market position, the company continuously partners and te
'/>"/>

SOURCE Lockheed Martin
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Lockheed Martin Team Wins Role on Key Department of Defense Biometrics Contract Vehicle
2. Platinum Solutions, Inc. Teams with Lockheed Martin on Federal Bureau of Investigations Next Generation Identification Program
3. Lockheed Martin Advances Biometrics Portfolio Through Cooperation Agreement With Cognitec
4. Professor Sir Martin Evans wins Nobel Prize for Medicine
5. UC San Diego senior named Churchill Scholar for extraordinary undergraduate research
6. CIC Named to Independent Research Firms Hot Banking Tech Companies to Watch in 2009 Report
7. University of Oklahoma researcher named 2008 AAAS Fellow
8. Tufts University Prof. Maria Flytzani-Stephanopoulos named as AAAS Fellow
9. Clemson physicist Apparao Rao named Fellow of the American Physical Society
10. NYU biologist Bonneau named among 20 "visionary" scientists under 40 by Discover magazine
11. Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...eptember 11, firefighters, police officers and amb... the World Trade Center complex. They battled to s...ed for survivors, tackled fires and evacuated as m...d an estimated 17,000 people. And making their job...ns: frightened workers and their relatives jammed ...
(Date:11/25/2009)... JOLLA, CAWhen you eat may be just as vital to you... Salk Institute for Biological Studies. Their expe... waning of thousands of genes in the liverthe body...food intake and not by the body,s circadian clock ...me determines the activity of a large number of ge...
(Date:11/24/2009)...ts that keep weakened and flabby arteries from col...months, those stents are no longer needed -- once ...sary. Previously, doctors had no choice but to lea...l Aviv University,s Department of Biomedical Engin...atform that carries drugs where they,re needed, th...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 1MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 4MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 5MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 6MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 7Locum Leaders Taps Hospitalist as Chief Medical Officer 3B Strengthens Leadership in Hospital Medicine Recruitment and Job Placement 53452 1Locum Leaders Taps Hospitalist as Chief Medical Officer 3B Strengthens Leadership in Hospital Medicine Recruitment and Job Placement 53452 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 1Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 3Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 4
...direct evidence that a single protein is critical ... human hemochromatosis, researchers report in the ...-which affects one in every 200 to 300 people in W... become overloaded with iron. Left untreated, the ...he new work, led by researchers at the Children,s ...
...College of Wisconsin research team, led by John W....logy and anatomy has found that embryonic stem cel... new tissue, which eventually may help doctors lea...heart attack. , The potential for ES cells to rep...s caused extraordinary interest in their therapeut...
...C. ?A new understanding of the causes for symptoms... in every 600 African-Americans, has resulted from... Center and Howard Hughes Medical Institute (HHMI)...thod for treating the disease, they said. , Their...cells to relax blood vessels through the release o...
Other Biology News:Iron exporter revealed that may explain common human disorder 2Iron exporter revealed that may explain common human disorder 3Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks 2Discovery Promises Simpler Therapy for Sickle Cell Disease 2Discovery Promises Simpler Therapy for Sickle Cell Disease 3
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... The FBI recently approved th...tories participating in or generating DNA records ... Madison, WI USA (PRWEB) -- The FBI rec...ystem for use by laboratories participating in, o...ex System (NDIS). NDIS currently contains more tha...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-First...e global specialty biopharmaceutical company, toda...opean Medicines Agency for,velaglucerase alfa, the...nt,for the treatment of Type 1 Gaucher disease. Th...erase alfa that has been submitted, with previous,...
(Date:11/24/2009)... , BOZEN, Italy, November 24 /PRNewswi... formed a new Canadian joint venture with a group ...o-based company will operate under the,name Health...nd support,Health Robotics, i.v. Room of the Futur...t offerings i.v.STATION(TM), i.v.SOFT(TM), and OMM...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...e nation,s top-10 GPOs(1), IRVINE, Calif., Jan. 2...ead-Through Motion and Low Perfusion pulse,oximetr...lier agreement,with HealthTrust Purchasing Group (...ies, including acute care hospitals, ambulatory su...practices, with an annual,purchasing volume of mor...
...surement of Women,s Ovarian ...ductive Specialists (GRS),today announced it will ...the Repromedix Plan Ahead(TM) test, an innovative ...s egg supply by combining multiple factors,includi...Inhibin B, and,FSH. The window of opportunity for ...
...t renin inhibitor with the diuretic hydroc...ow combination of Tekturna and HCTZ resulted in si...ompared to either drug alone - Many treated patie... medicines - single-tablet combinations simplify ...f pills patients take, EAST HANOVER, N.J., Jan. 2...
Other Biology Technology:Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 2Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 3Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 4Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock 2Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock 3Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 2Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 3Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 4Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 5
Disposable Cuvettes, 1,000/pkg from Promega
TNT T7 Coupled Wheat Germ Extract System from Promega
STP3, T7 from Novagen
Cell Lysis Buffer (10X) from Cell Signaling Technology
Biology Products: